Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice

Key Points

• Bone marrow mesenchymal stem cells significantly improve outcomes in multiple sclerosis models, enhancing overall function.
• Quantitative assessment shows notable changes in cerebellar structure and function with stem cell treatment.
• Assessment using quantitative cerebellar microscopy revealed profound structural improvements post-intervention.
• Highlights potential for future therapies in multiple sclerosis, though results were obtained from mouse models; further studies are needed.